(678) 892-9230
Find Labs
Clinician-Led Care
Weight Loss · Hormones · Aesthetics
Telehealth Care Available
Book Consultation
HRT Conditions Vaginal Atrophy
HRT · Tactus Health

Vaginal Atrophy: Symptoms and Relief

Vaginal dryness, painful intercourse, and recurrent urinary symptoms after menopause are not something to live with quietly. Local estrogen treatment is highly effective and rarely contraindicated.

Vaginal Atrophy in Menopause: Causes and Treatment

Vaginal atrophy, now more accurately called the genitourinary syndrome of menopause, is the thinning, drying, and inflammation of vaginal and lower urinary tract tissue caused by sustained low estrogen levels. Estrogen receptors are abundant in vaginal, vulvar, urethral, and bladder tissue. When estradiol drops at menopause, those tissues lose lubrication, elasticity, and the protective acidic environment that limits bacterial growth.

The clinical pattern includes vaginal dryness, burning, itching, painful intercourse, post-coital bleeding, urinary urgency, frequent urination, and recurrent urinary tract infections. Unlike hot flashes, the genitourinary symptoms do not improve with time. They tend to progress without treatment. The Mayo Clinic overview on vaginal atrophy confirms that local estrogen therapy is highly effective and is recommended even for many women who cannot or do not want systemic hormone therapy. For the bladder symptoms specifically, including which pattern of leaking you have and what the evidence supports, see our guide to menopause and urinary incontinence.

For broader context on this condition specifically, see our overview on vaginal atrophy. The clinical priority on this page is normalizing the conversation, because most women never bring this up to their primary care provider despite how common and treatable it is.

Differential diagnosis matters. Lichen sclerosus, vulvar dermatitis, infection, and pelvic floor dysfunction can all produce overlapping symptoms. Our medical team performs a clinical exam and screens for these conditions before initiating treatment, because some require different management.

How Tactus Health Evaluates Vaginal Atrophy

The evaluation begins with a clinical history that documents symptom onset, severity, sexual activity status, urinary symptoms, and any prior treatments tried. A focused pelvic exam confirms the tissue changes and rules out other causes of vulvar symptoms. Our licensed providers approach the conversation directly because most women find that the relief comes once treatment starts, not once it is finally discussed.

Lab work is typically minimal for genitourinary symptoms because the diagnosis is clinical, but estradiol, FSH, and a urinalysis with culture (when urinary symptoms are present) are commonly added. Treatment options include vaginal estradiol cream, tablets, or rings, vaginal DHEA inserts, oral ospemifene in select cases, and supportive measures like vaginal moisturizers and lubricants. Most women experience meaningful improvement within 4 to 12 weeks.

Common Questions About Vaginal Atrophy

Can vaginal estrogen treat vaginal atrophy? +

Yes. Local vaginal estrogen is the most effective treatment for the genitourinary syndrome of menopause. It restores tissue thickness, lubrication, and the protective acidic environment that limits urinary infections. Systemic absorption is minimal at standard doses, which is why most women who cannot use systemic hormone therapy can still safely use vaginal estrogen. Most patients see significant improvement within 4 to 12 weeks and ongoing benefit with continued use.

How do I know if my symptoms are vaginal atrophy? +

The classic pattern is dryness, burning, painful intercourse, urinary urgency, and recurrent UTIs that begin or worsen after menopause. Symptoms that began before menopause or that include unusual lesions, bleeding outside intercourse, or persistent itching despite treatment may point to other diagnoses. A focused exam and history sort the picture quickly.

What tests check for vaginal atrophy? +

The diagnosis is largely clinical from history and a focused pelvic exam. Our medical team adds estradiol, FSH, and a urinalysis with culture when urinary symptoms are present. Specialized vaginal pH testing or biopsy is reserved for cases where the picture is unclear or where another condition needs to be ruled out.

BHRT in Sugar Hill, Georgia

End the Discomfort. Restore the Tissue.

Free consultation. Complete hormonal evaluation. In-person care with our medical team in Sugar Hill, Georgia.

Reviewed By
Dr. Ashar N., DNP, APRN, FNP-C, PMHNP-BC, Co-Founder and Medical Director at Tactus Health reviewing vaginal atrophy treatment menopause treatment
Medical Reviewer
Dr. Ashar N., DNP, APRN, FNP-C, PMHNP-BC
Co-Founder & Medical Director, Tactus Health

Reviewed May 2026 against the 2022 Menopause Society Position Statement on Hormone Therapy and current BHRT prescribing standards.

Not sure if your symptoms are hormonal?

Our free menopause assessment takes about three minutes. Answer 11 questions and get a read on whether your symptoms fit perimenopause or menopause, and which labs help confirm it.

Take the free assessment →

Educational screening, not a diagnosis. Only a provider can confirm.